Combining two unique AI platforms for the discovery of novel therapeutic targets & preclinical validation of synthetic biomolecules to treat AML

Research unit

INNOSUISSE

Project number

109.188 INT-LS

Project title

Combining two unique AI platforms for the discovery of novel therapeutic targets & preclinical validation of synthetic biomolecules to treat AML

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals, Deep learning, Medtech, Machine learning, Personalised medicine, Artificial/local/extended/networked intelligence
Abstract (English)	AMPLY Discovery and Nexco Analytics are combining their novel AI-based drug discovery approaches to advance a unique first-in-class platform, which will identify, and triage, novel targets and discover, and validate, new biologic therapeutic candidates to treat AML.